HB 919 Louisiana House · 2026 Regular Session

INSURANCE/HEALTH: Provides relative to pharmacy benefit managers (RE +$238,163 SG EX See Note)

HB 919 requires pharmacy benefit managers (PBMs) in Louisiana to reimburse pharmacies at least the National Average Drug Acquisition Cost (NADAC) plus the state's professional dispensing fee per prescription, with a minimum $12 per prescription. It prohibits PBMs from owning or contracting with pharmacies (including subsidiaries) and mandates annual transparency reports detailing foreign subsidiaries and financial arrangements with drug manufacturers. PBMs violating these rules face fines up to $100,000 per violation for executives, with unlimited liability for large PBMs ($500M+ revenue). The law applies retroactively to prescriptions filled between January 1, 2025, and December 1, 2025, and becomes fully effective for new requirements in 2027. These provisions directly affect pharmacies, pharmacists, and PBMs operating in Louisiana.

Issues: ✓ Healthcare

Bill status passed 3 of 5 stages cleared

Introduction

Feb 2026

Committee Review

Mar 2026

House Passage

Mar 2026

Senate Passage

Governor

Introduced Feb 27, 2026 Last action Apr 1, 2026

Maddy AI version diff · 2 comparisons

What changed between versions

HB919 Reengrossed → HB919 Engrossed · 4 edits · Mar 30, 2026

MODERATE

The bill was renumbered from 'Reengrossed' to 'Engrossed' and simplified the list of sponsors from a group of representatives to a single representative. The core policy text regarding pharmacy reimbursement and transparency was largely preserved but underwent significant reformatting, with the addition of a new prohibition against PBM-owned pharmacies receiving under-reimbursement and a new penalty for individual officers who willfully violate the law.

Scope change

The bill's scope regarding the number of sponsors was narrowed from a multi-member group to a single sponsor, while the substantive policy scope regarding pharmacy reimbursement protections was expanded with new prohibitions on PBM-owned pharmacies and unlimited liability for large PBM revenues.

ENFORCEMENT

Added a specific penalty for individual officers, directors, or employees who willfully violate under-reimbursement rules, allowing for imprisonment or fines paid by the individual rather than the company.

REQUIREMENT

Added a new prohibition stating that pharmacy benefit managers cannot reimburse any pharmacy they own, own a subsidiary of, or are affiliated with.

TECHNICAL

Changed the document status from 'Reengrossed' to 'Engrossed' and reduced the list of bill sponsors from multiple representatives to a single representative.

Reformatted the text of the new sections (R.S. 22:1868 and R.S. 1870) to use a different numbering style (a, b, c) and reorganized the layout, though the core reimbursement thresholds appear consistent.

Floor votes · House Mar 30, 2026

How they voted

80–16

Passed · 9 other

Total votes 105

Mar 30, 2026

D Democratic33

10 Yea 16 Nay 7

48% Nay

R Republican72

70 Yea 2

97% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 30, 2026

Lower · Passed

Read third time by title, amended, roll called on final passage, yeas 80, nays 16. Finally passed, title adopted, ordered to the Senate.

lower

Mar 18, 2026

Lower · Passed

Reported with amendments (14-0).

lower

Mar 9, 2026

Committee

Read by title, under the rules, referred to the Committee on Health and Welfare.

lower

Feb 27, 2026

Committee

Under the rules, provisionally referred to the Committee on Health and Welfare.

lower

1 primary · 21 co-sponsors